Nephrotoxicity of combination drug therapy in metastatic renal cancer-Reference-Cited by-同舟云学术

Nephrotoxicity of combination drug therapy in metastatic renal cancer

Published:2023-11-16 Issue:3 Volume:19 Page:153-162
ISSN:1996-1812
Container-title:Cancer Urology
language:
Short-container-title:Onkourologiâ

Author:

Titov K. S.¹^ORCID,Shutov E. V.²^ORCID,Alimov A. A.¹^ORCID,Lebedev S. S.²^ORCID,Kirichek A. A.³^ORCID,Zapirov G. M.⁴^ORCID

Affiliation:

1. S.P. Botkin City Clinical Hospital, Moscow Healthcare Department; Peoples’ Friendship University of Russia named after Patrice Lumumba

2. S.P. Botkin City Clinical Hospital, Moscow Healthcare Department; Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia

3. S.P. Botkin City Clinical Hospital, Moscow Healthcare Department

4. Peoples’ Friendship University of Russia named after Patrice Lumumba

Abstract

The review covers reduced kidney function in the context of renal cell carcinoma. According to international studies, some patients already have chronic kidney disease at time of disease onset. Surgical treatment leads to a decrease in the total number of functioning nephrons. Drug therapy causes several adverse events including nephrotoxicity. The review discusses the problem of using combination regimens in patients with solitary kidney.

Publisher

Publishing House ABV Press

Subject

Urology,Nephrology,Radiology, Nuclear Medicine and imaging,Oncology,Surgery

Reference69 articles.

1. World Health Organization. The Global Cancer Observatory. Available at: https://gco.iarc.fr.

2. Malignant tumors in Russia in 2020 (morbidity and mortality). Eds.: A.D. Kaprin, V.V. Starinskiy, A.O. Shakhzadova. Moscow: MNIOI im. P.A. Gertsena - filial FGBU “NMITS radiologii” Minzdrava Rossii, 2021. 252 p. (In Russ.).

3. SEER Explorer. Available at: https://seer.cancer.gov/explorer/index.html (accessed March 2, 2020).

4. Heng D.Y., Wells J.C., Rini B. et al. Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium. Eur Urol 2014;66(4):704-10. DOI: 10.1016/j.eururo.2014.05.034

5. Mejean A., Ravaud A., Thezenas S. et al. Sunitinib alone or after nephrectomy in metastatic renal-cell carcinoma. N Engl J Med 2018;379(5):417-27. DOI: 10.1056/NEJMoa1803675